Literature DB >> 29682392

A Rare Case of Multifocal Prostatic Blue Nevus.

Elias J Farran1, Preston S Kerr1, Christopher D Kosarek1, Joseph Sonstein1, Eduardo J Eyzaguirre2.   

Abstract

Prostatic blue nevus is a rare benign pathologic diagnosis most commonly diagnosed incidentally on many different types of prostate specimens. Blue nevus is the deposition of stromal melanin characterized by spindle cells within the fibromuscular stroma which stains positive for melanin-specific stains Fontana-Masson and S100 and stains negative for CD68, HMB45, and iron stains. We report the case of a multifocal and bilateral blue nevus in a 52-year-old Hispanic male who presented with an elevated prostate-specific antigen of 4.3 and mild obstructive lower urinary tract symptoms, found by transrectal ultrasound-guided prostate needle biopsy. The biopsy also revealed benign prostatic tissue with postatrophic hyperplasia and chronic inflammation. This is the 35th reported case of prostatic blue nevus and the third to show multifocal blue nevus.

Entities:  

Year:  2018        PMID: 29682392      PMCID: PMC5841115          DOI: 10.1155/2018/7820717

Source DB:  PubMed          Journal:  Case Rep Urol


1. Introduction

Melanocytic lesions are an often-overlooked pathologic process that occurs in the prostate. Of these extremely rare lesions, the most commonly found is the prostatic blue nevus, also known as pigmented melanocytosis or prostatic pigmentary nevohyperplasia [1]. Blue nevus is the deposition of stromal melanin characterized by spindle cells within the fibromuscular stroma which stains positive for melanin-specific stains Fontana-Masson and S100, while it stains negative for CD68 proteins, HMB45, and iron stains [1]. Blue nevus is asymptomatic and benign and has been incidentally diagnosed following prostatectomy (11 cases), transurethral resection of the prostate (TURP, 6 cases), autopsy (5 cases), and transrectal ultrasound-guided prostate needle biopsy (TRUS PNBx, 2 cases) (Table 1).
Table 1

Literature review of blue nevus cases.

Source, year ProcedureAge (years)RaceExtent
Nigogosyan et al. [2], 1963Autopsy50NAFocal

Guillan and Zelman [3], 1970AutopsyNANAFocal

Jao et al. [4], 1971Prostatectomy76WFocal

Gardner and Spitz [5], 1971Autopsy20AAFocal

Block et al. [6], 1972Prostatectomy66WFocal

Langley and Weitzner [7], 1974NANAWFocal

Tannenbaum [8], 1974NANANAFocal

Rios and Wright [9], 1976Autopsy67AAFocal

Kovi et al. [10], 1977TURP65AAFocal

Ro et al. [11], 1988 TURP68AAFocal
TURP76WFocal

Botticelli et al. [12], 1989Prostatectomy69WFocal
Prostatectomy70WFocal
Prostatectomy66NAFocal

Lew et al. [13], 1991Prostatectomy80AAFocal

Martinez Martinez et al. [14], 2017 Prostatectomy81NAFocal
Prostatectomy69NAFocal

Vesga et al. [15], 1995NANANAFocal

Redondo Martínez et al. [16], 1998TURP58NAFocal

Cuervo Pinna et al. [17], 2001Prostatectomy71NAFocal

Di Nuovo et al. [18], 2002Needle Biopsy66NAFocal

Humphrey [19], 2003Needle Biopsy70NAFocal

Anderco et al. [20], 2010TURP69NAFocal

Kudva and Hegde [21], 2010TURP53NAFocal

Raspollini et al. [22], 2011Prostatectomy64NAFocal

Montalvo and Redrobán [23], 2013Prostatectomy63HFocal

Ponte et al. [24], 2014Prostatectomy69WMultifocal

Ponte et al. [25], 2016Prostatectomy74NAMultifocal

Present reportNeedle biopsy52HMultifocal

AA, African American; H, Hispanic; W, non-Hispanic White, TURP, transurethral resection of the prostate.

2. Case Presentation

A 52-year-old healthy Hispanic male presented to an outpatient urology clinic with an elevated prostate-specific antigen (PSA) of 4.1 along with mild obstructive lower urinary tract symptoms. There was no family history of prostate cancer. The physical examination including the digital rectal examination was unremarkable. The patient was seen again 3 months later with a PSA of 4.3 and after discussion with the patient he elected to undergo a 12-core TRUS PNBx. The following month when the biopsy was performed, the PSA had slightly decreased to 3.4. The prostate was visualized in the sagittal and transverse planes via ultrasound probe and was unremarkable. Volume was measured to be 33 cm3 (PSA density of 0.10 ng/mL/g). Final pathology demonstrated blue nevus in one out of six cores on the right and two out of six cores on the left. On microscopic analysis with hematoxylin-eosin stain, individual heavily pigmented spindle cells distributed in between prostatic stroma and glands were noted (Figures 1 and 2). The remaining specimen consisted of benign prostatic tissue with postatrophic hyperplasia and chronic inflammation. The patient's voiding symptoms improved with terazosin and no further workup was undertaken. The patient is now being followed up for routine prostate cancer surveillance as per the American Urological Association (AUA) guidelines [26].
Figure 1

Low-power view of blue nevus in the prostate as a cluster of pigmented spindle to round cells in the stroma (hematoxylin-eosin, original magnification: ×10).

Figure 2

Individual heavily pigmented spindle cells distributed in between prostatic stroma and glands (hematoxylin-eosin, original magnification: ×20).

3. Discussion

Blue nevus is a rare lesion of dermal melanocytes most commonly found in the skin, but it has been reported in the oral mucosa, sclera, cervix, vagina, and prostate [27]. The appearance of this lesion in nonintegumentary tissues is not fully understood; the prevailing hypothesis is that melanoblasts originate in the neural crest and migrate with the mesoderm into connective tissue, where they remain latent until maturing into melanocytes [28]. Proliferation induced by inflammation or other insults of these latent melanoblasts can explain acquired cases of blue nevi [29]. An alternative hypothesis proposes development from the neoplastic growth of Schwann cells of dermal nerves which became melanogenetic as they proliferated [30]. Blue nevus grossly appears as multiple brown to black streaks or nodules that range in size from 0.1 cm to 2.0 cm [1]. Microscopically, prostatic blue nevus consists of stromal cells that contain finely granular brown or black pigment, which may also be seen in the extracellular matrix [11]. The cells can extensively infiltrate the surrounding fibromuscular stroma individually or as irregularly clustered collections [4]. The pigment-laden cells are usually spindle in shape with bipolar, elongated dendritic cytoplasmic processes but can also be round, ovoid, or polygonal (Figures 1 and 2). The nuclei have been described as centrally located and often obscured by the abundant melanin present in the cytoplasm [2]. It is also important to recognize the benign nature of these lesions and not confuse them with more aggressive melanocytic lesions of the prostate such as malignant melanoma. Hypercellularity, diffuse atypia, increased mitotic activity, and positive immunostaining for HMB45 should help in differentiating malignant melanoma from blue nevus.

4. Conclusion

Review of the literature indicates that blue nevus typically presents as a single focus and is characteristically diagnosed on TURP and prostatectomy specimens. Although no risk factors for blue nevus have been identified, our discovery of just the second case in a Hispanic male may suggest variability in risk among different races/ethnicities [23]. Of the other 34 reported cases of blue nevus, only two have shown multifocal blue nevus [24, 25]. Diagnosis is most often made on prostatectomy or TURP specimens; however, there have been two reported cases documenting diagnosis by TRUS PNBx, making this the third reported case [18, 19]. As in all other cases, blue nevus presented in an asymptomatic fashion. The importance of this case lies in the rarity of such a diagnosis as it is highly likely that both urologist and pathologist alike have not come across such a diagnosis. The recognition of the benign nature of blue nevus and multifocal blue nevus need to be emphasized as further workup and surveillance outside of routine prostate cancer screening carries no benefit. As always, all routine prostate cancer screening should follow the shared decision-making mantra endorsed by the AUA [26].
  29 in total

Review 1.  [Prostatic blue nevus. Terminology standardization of prostatic pigmented lesions].

Authors:  C Cuervo Pinna; E Godoy Rubio; J L Parra Escobar; E Sánchez Blasco; J Valverde Valverde; J Moreno Casado
Journal:  Actas Urol Esp       Date:  2001-03       Impact factor: 0.994

2.  A STUDY OF THE HISTOGENESIS OF EXPERIMENTAL MELANOTIC TUMORS RESEMBLING CELLULAR BLUE NEVI: THE EVIDENCE IN SUPPORT OF THEIR NEUROGENIC ORIGIN.

Authors:  T NAKAI; H RAPPAPORT
Journal:  Am J Pathol       Date:  1963-08       Impact factor: 4.307

3.  Prostatic blue nevus.

Authors:  Denisa Anderco; Elena Lazăr; Sorina Tăban; Fl Miclea; Alis Dema
Journal:  Rom J Morphol Embryol       Date:  2010       Impact factor: 1.033

Review 4.  Blue nevus of the prostate.

Authors:  Virginia L Dailey; Omar Hameed
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

5.  Blue nevus of the prostate: ultrastructural study.

Authors:  J Kovi; A G Jackson; M A Jackson
Journal:  Urology       Date:  1977-05       Impact factor: 2.649

6.  Blue nevus and melanosis of prostate.

Authors:  J W Langley; S Weitzner
Journal:  J Urol       Date:  1974-09       Impact factor: 7.450

7.  Blue nevi and other melanotic lesions of the prostate: report of 3 cases and review of the literature.

Authors:  N L Block; D Weber; R Schinella
Journal:  J Urol       Date:  1972-01       Impact factor: 7.450

8.  The development of melanoblasts from leg bud mesenchyme grown in the celom of chick embryos.

Authors:  M Ahmad; W M Reams
Journal:  Anat Anz       Date:  1978

9.  Acquired, bilateral nevus of Ota-like macules.

Authors:  Y Hori; M Kawashima; K Oohara; A Kukita
Journal:  J Am Acad Dermatol       Date:  1984-06       Impact factor: 11.527

10.  Blue nevi of the Müllerian tract: case series and review of the literature.

Authors:  Kenneth J Craddock; Bizhan Bandarchi; Mahmoud A Khalifa
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.